Global Pharmaceutical Packaging Manufacturer Selects Kneat

Executive Summary

• Kneat announced the signing of a Master Services Agreement with a large U.S.-based global pharmaceutical packaging and drug‑delivery manufacturer.
• The new customer operates >45 facilities worldwide (including >12 GMP sites) and employs ~13,000 people.
• Initial deployment will use Kneat Gx for Commissioning, Qualification & Validation at the lead site, with planned expansion to all other GMP locations.

Key Details

• Customer Profile: Global pharma packaging/drug‑delivery manufacturer; >45 manufacturing facilities; >12 GMP‑regulated sites; ~13,000 employees across North America, Europe, Asia, and South America.
• Agreement Scope: Master Services Agreement for Kneat Gx platform covering Commissioning, Qualification, and Validation (CQV) activities.
• Implementation Plan: Phase 1 – deployment at the lead site; subsequent rollout to all remaining GMP sites worldwide.
• Strategic Significance: Represents Kneat’s second major win of 2026, reinforcing its position as a standard‑setting digital validation provider in highly regulated industries.
• CEO Quote: “Regulated manufacturers increasingly rely on Kneat because of its trusted system of record for validation… We’re excited to partner with this global leader…” – Eddie Ryan, CEO, Kneat.

Notable Quotes

“Regulated manufacturers increasingly rely on Kneat because of its trusted system of record for validation, built to support the highest standards of data integrity and compliance. We’re excited to partner with this global leader as they continue to strengthen their quality and manufacturing excellence.” – Eddie Ryan, CEO, Kneat

Materiality Assessment: Material – Positive (new high‑value contract with a major global manufacturer expected to drive revenue growth and market penetration).